Market Closed - Nasdaq Stockholm 16:24:49 01/07/2024 BST 5-day change 1st Jan Change
0.9 SEK -0.66% Intraday chart for NEOS AB +7.14% -59.09%

Business Summary

NeoDynamics AB (publ) is a Sweden-based company engaged in the medical industry. The Company focuses on developing and commercializing products for breast cancer screening, imaging, and breast cancer treatments. The Company’s product NeoNavia, enables a pulse biopsy system for ultrasound guided tissue sampling. It consists of a base unit, a handheld driver and three different types of biopsy needles. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumour whilst enabling tissue samples from both breasts and lymph nodes. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at clinics in United Kingdom, Germany, and Sweden.

Number of employees: 13

Sales per Business

SEK in Million2022Weight2023Weight Delta
Diagnosis & Treatment of Breast Cancer
100.0 %
0 100.0 % 0 100.0 % +138.19%

Sales per region

SEK in Million2022Weight2023Weight Delta
Sweden
100.0 %
0 100.0 % 0 100.0 % +138.19%

Managers

Managers TitleAgeSince
Chief Tech/Sci/R&D Officer - 31/01/09
Chief Operating Officer - 30/04/12
Sales & Marketing - 07/11/22
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 31/12/17
Director/Board Member 71 31/12/14
Director/Board Member - 31/12/20
Chairman 56 31/12/15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,606,779 5,193,274 ( 15.93 %) 0 15.93 %

Company contact information

NeoDynamics AB

Lejonvägen 14

181 32, Lidingö

+46 8 52 27 96 67

http://www.neodynamics.se
address NEOS AB(NEOD)